Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
Front Immunol ; 13: 998406, 2022.
Article in English | MEDLINE | ID: covidwho-2071096

ABSTRACT

[This corrects the article DOI: 10.3389/fimmu.2021.743022.].

3.
Front Immunol ; 12: 743022, 2021.
Article in English | MEDLINE | ID: covidwho-1450814

ABSTRACT

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. The virus primarily affects the lungs where it induces respiratory distress syndrome ranging from mild to acute, however, there is a growing body of evidence supporting its negative effects on other system organs that also carry the ACE2 receptor, such as the placenta. The majority of newborns delivered from SARS-CoV-2 positive mothers test negative following delivery, suggesting that there are protective mechanisms within the placenta. There appears to be a higher incidence of pregnancy-related complications in SARS-CoV-2 positive mothers, such as miscarriage, restricted fetal growth, or still-birth. In this review, we discuss the pathobiology of COVID-19 maternal infection and the potential adverse effects associated with viral infection, and the possibility of transplacental transmission.


Subject(s)
COVID-19/pathology , Placenta/pathology , Placenta/virology , Pregnancy Complications, Infectious/virology , Abortion, Spontaneous/virology , Angiotensin-Converting Enzyme 2/metabolism , Female , Fetal Growth Retardation/virology , Humans , Maternal-Fetal Exchange/physiology , Pregnancy , SARS-CoV-2/pathogenicity , Serine Endopeptidases/metabolism , Stillbirth
SELECTION OF CITATIONS
SEARCH DETAIL